12:00 AM
Feb 09, 2009
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Promus Element Stent: Phase III started

Boston Scientific began the single-blind, international Phase III PLATINUM program in 1,728 patients to compare the PROMUS Element bare-metal stent to the PROMUS everolimus-eluting coronary stent. The program will include 3 trials, including the Workhorse study that will enroll patients...

Read the full 180 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >